Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Jelastopulu, Eleni ^a   Giourou, Evangelia ^a   Merekoulias, Giorgos ^a   Mestousi, Angeliki ^b   Moratis, Eleftherios ^b   Alexopoulos, Evangelos C ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b Department of Medical Affairs ^*  (Greece)

Author keywords

Correlation; PANSS; PSP; Reliability; Social functioning; Validity

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; AGGRESSION; ARTICLE; CATATONIC SCHIZOPHRENIA; CLINICAL PRACTICE; CONTROLLED STUDY; CONVERGENT VALIDITY; CORRELATIONAL STUDY; FEMALE; FOLLOW UP; GREECE; HEBEPHRENIA; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PERSONAL AND SOCIAL PERFORMANCE SCALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; RESIDUAL SCHIZOPHRENIA; SCHIZOPHRENIA; SOCIAL INTERACTION; SYMPTOM ASSESSMENT; CHRONIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; NEGATIVE SYNDROME; POSITIVE SYNDROME; SCHIZOPHRENIA ASSESSMENT; SEX RATIO; ADOLESCENT; MIDDLE AGED; PSYCHOLOGY; QUALITY OF LIFE; REGRESSION ANALYSIS; SOCIAL ADAPTATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGGRESSION; FEMALE; GREECE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; REGRESSION ANALYSIS; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; YOUNG ADULT;

EID: 84903806709     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-197     Document Type: Article

References (37)

1. Bottlender R, Strauss A, Moller HJ. Social disability in schizophrenic, schizoaffective and affective disorders 15 years after first admission. Schizophr Res 2010, 116:9-15. 10.1016/j.schres.2009.10.008, 19896334.
2. Hafner H, Loffler W, Maurer K, Hambrecht M, An der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand 1999, 100:105-118. 10.1111/j.1600-0447.1999.tb10831.x, 10480196.
3. Stanghellini G, Ballerini M. Dis-sociality: the phenomenological approach to social dysfunction in schizophrenia. World Psychiatry 2002, 1:102-106. 1489864, 16946867.
4. Association AP. Diagnostic and Statistical Manual of Mental Disorders 1994, Washington DC: American Psychiatric Association.
5. Burns T, Patrick D. Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatr Scand 2007, 116:403-418. 10.1111/j.1600-0447.2007.01108.x, 17941964.
6. Brune M, Schaub D, Juckel G, Langdon R. Social skills and behavioral problems in schizophrenia: the role of mental state attribution, neurocognition and clinical symptomatology. Psychiatry Res 2011, 190:9-17. 10.1016/j.psychres.2010.03.015, 20417974.
7. Corcoran CM, Kimhy D, Parrilla-Escobar MA, Cressman VL, Stanford AD, Thompson J, David SB, Crumbley A, Schobel S, Moore H, Malaspina D. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychol Med 2011, 41:251-261. 10.1017/S0033291710000802, 3376746, 20444306.
8. Smith TE, Hull JW, Huppert JD, Silverstein SM. Recovery from psychosis in schizophrenia and schizoaffective disorder: symptoms and neurocognitive rate-limiters for the development of social behavior skills. Schizophr Res 2002, 55:229-237. 10.1016/S0920-9964(01)00231-6, 12048146.
9. Weinberg D, Shahar G, Davidson L, McGlashan TH, Fennig S. Longitudinal associations between negative symptoms and social functioning in schizophrenia: the moderating role of employment status and setting. Psychiatry 2009, 72:370-381.
10. Rocca P, Montemagni C, Castagna F, Giugiario M, Scalese M, Bogetto F. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:373-379. 10.1016/j.pnpbp.2009.01.002, 19211031.
11. Brune M. Emotion recognition, 'theory of mind', and social behavior in schizophrenia. Psychiatry Res 2005, 133:135-147. 10.1016/j.psychres.2004.10.007, 15740990.
12. Stefanopoulou E, Lafuente AR, Saez Fonseca JA, Huxley A. Insight, global functioning and psychopathology amongst in-patient clients with schizophrenia. Psychiatr Q 2009, 80:155-165. 10.1007/s11126-009-9103-9, 19526340.
13. MacEwan TH, Athawes RW. The Nithsdale Schizophrenia Surveys. XV. Social adjustment in schizophrenia: associations with gender, symptoms and childhood antecedents. Acta Psychiatr Scand 1997, 95:254-258. 10.1111/j.1600-0447.1997.tb09628.x, 9111860.
14. Rocca P, Pulvirenti L, Montemagni C, Rasetti R, Rocca G, Bogetto F. Basic symptoms in stable schizophrenia: relations with functioning and quality of life. Clin Neuropsychiatry 2010, 7:100-110.
15. Karow A, Naber D. Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology (Berl) 2002, 162:3-10. 10.1007/s00213-002-1052-z, 12107610.
16. Juckel G, Morosini PL. The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia. Curr Opin Psychiatry 2008, 21:630-639. 10.1097/YCO.0b013e328314e144, 18852573.
17. Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 2000, 101:323-329.
18. Patrick DL, Burns T, Morosini P, Rothman M, Gagnon DD, Wild D, Adriaenssen I. Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia. Curr Med Res Opin 2009, 25:325-338. 10.1185/03007990802611919, 19192977.
19. Juckel G, Schaub D, Fuchs N, Naumann U, Uhl I, Witthaus H, Hargarter L, Bierhoff HW, Brune M. Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia. Schizophr Res 2008, 104:287-293. 10.1016/j.schres.2008.04.037, 18595665.
20. Nasrallah H, Morosini P, Gagnon DD. Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia. Psychiatry Res 2008, 161:213-224. 10.1016/j.psychres.2007.11.012, 18848731.
21. Kane J, Canas F, Kramer M, Ford L, Gassmann-Mayer C, Lim P, Eerdekens M. Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial. Schizophr Res 2007, 90:147-161. 10.1016/j.schres.2006.09.012, 17092691.
22. Marder SR, Kramer M, Ford L, Eerdekens E, Lim P, Eerdekens M, Lowy A. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study. Biol Psychiatry 2007, 62:1363-1370. 10.1016/j.biopsych.2007.01.017, 17601495.
23. Davidson M, Emsley R, Kramer M, Ford L, Pan G, Lim P, Eerdekens M. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study. Schizophr Res 2007, 93:117-130. 10.1016/j.schres.2007.03.003, 17466492.
24. Ginsberg DL, Schooler NR, Buckley PF, Harvey PD, Weiden PJ. Optimizing treatment of schizophrenia. Enhancing affective/cognitive and depressive functioning. CNS Spectr 2005, 10:1-13. discussion 14-15.
25. Franz M. Possibilities and limitations of the use of quality of life as outcome-indicator in schizophrenic patients. Psychiatr Prax 2006, 33:317-322. 10.1055/s-2006-940194, 17024580.
26. Angermeyer MC, Holzinger A, Matschinger H. Quality of life-what it means to me... Results of a survey among schizophrenic patients. Psychiatr Prax 1999, 26:56-60.
27. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276. 10.1093/schbul/13.2.261, 3616518.
28. Lykouras E, Botsis A, Oulis P. The Positive and Negative Syndrome Scale (PANSS) [in Greek] 1994, Tsiveriotis Ed: Athens, Greece.
29. Apiquian R, Elena Ulloa R, Herrera-Estrella M, Moreno-Gomez A, Erosa S, Contreras V, Nicolini H. Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia. Schizophr Res 2009, 112:181-186. 10.1016/j.schres.2009.03.028, 19398302.
30. Fleischhacker WW, Kemmler G. The clinical relevance of percentage improvements on the PANSS score. Neuropsychopharmacology 2007, 32:2435-2436. 10.1038/sj.npp.1301391, 17940536.
31. Eack SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull 2007, 33:1225-1237. 10.1093/schbul/sbl071, 2632363, 17204532.
32. Woon PS, Chia MY, Chan WY, Sim K. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:463-468. 10.1016/j.pnpbp.2010.01.014, 20109511.
33. Rocca P, Giugiario M, Montemagni C, Rigazzi C, Rocca G, Bogetto F. Quality of life and psychopathology during the course of schizophrenia. Compr Psychiatry 2009, 50:542-548. 10.1016/j.comppsych.2008.12.002, 19840592.
34. Tianmei S, Liang S, Yun'ai S, Chenghua T, Jun Y, Jia C, Xueni L, Qi L, Yantao M, Weihua Z, Hongyan Z. The Chinese version of the Personal and Social Performance Scale (PSP): validity and reliability. Psychiatry Res 2011, 185:275-279. 10.1016/j.psychres.2010.05.001, 20542575.
35. Lindenmayer JP, Bernstein-Hyman R, Grochowski S. A new five factor model of schizophrenia. Psychiatr Q 1994, 65:299-322. 10.1007/BF02354306, 7831416.
36. Lancon C, Auquier P, Nayt G, Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophr Res 2000, 42:231-239. 10.1016/S0920-9964(99)00129-2, 10785581.
37. Hough D, Nuamah IF, Lim P, Sampson A, Gagnon DD, Rothman M. Independent effect of paliperidone extended release on social functioning beyond its effect on positive and negative symptoms of schizophrenia: a mediation analysis. J Clin Psychopharmacol 2009, 29:496-497. 10.1097/JCP.0b013e3181b5f40b, 19745652.